The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Recombinant humanized anti-PD-1 monoclonal antibody toripalimab in patients with metastatic urothelial carcinoma: Results of an open-label phase II clinical study Polaris-03.
 
Xinan Sheng
No Relationships to Disclose
 
Haige Chen
No Relationships to Disclose
 
Bin Hu
No Relationships to Disclose
 
Xudong Yao
No Relationships to Disclose
 
Ziling Liu
No Relationships to Disclose
 
Xin Yao
No Relationships to Disclose
 
Hongqian Guo
No Relationships to Disclose
 
Yi Hu
No Relationships to Disclose
 
Zhigang Ji
No Relationships to Disclose
 
Hong Luo
No Relationships to Disclose
 
Benkang Shi
No Relationships to Disclose
 
Jiyan Liu
No Relationships to Disclose
 
Jin WU
No Relationships to Disclose
 
Fangjian Zhou
No Relationships to Disclose
 
Zhisong He
No Relationships to Disclose
 
Jinhai Fan
No Relationships to Disclose
 
Yiran Huang
No Relationships to Disclose
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere